SEARCH

SEARCH BY CITATION

References

  • Adams M. D., Celniker S. E., Holt R. A. et al. (2000) The genome sequence of Drosophila melanogaster. Science 287, 21852195.
  • Akimoto A., Wada H. and Hayashi S. (2005) Enhancer trapping with a red fluorescent protein reporter in Drosophila. Dev. Dyn. 233, 993997.
  • Ambegaokar S. S. and Jackson G. R. (2011) Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet. 20, 49474977.
  • Bartolome C., Maside X. and Charlesworth B. (2002) On the abundance and distribution of transposable elements in the genome of Drosophila melanogaster. Mol. Biol. Evol. 19, 926937.
  • Bellen H. J., Levis R. W., Liao G. et al. (2004) The BDGP gene disruption project: single transposon insertions associated with 40% of Drosophila genes. Genetics 167, 761781.
  • Bellen H. J., Levis R. W., He Y. et al. (2011) The Drosophila gene disruption project: progress using transposons with distinctive site specificities. Genetics 188, 731743.
  • Berger J., Suzuki T., Senti K. A., Stubbs J., Schaffner G. and Dickson B. J. (2001) Genetic mapping with SNP markers in Drosophila. Nat. Genet. 29, 475481.
  • Bier E. (2005) Drosophila, the golden bug, emerges as a tool for human genetics. Nat. Rev. Genet. 6, 923.
  • Bier E., Vaessin H., Shepherd S. et al. (1989) Searching for pattern and mutation in the Drosophila genome with a P-lacZ vector. Genes Dev. 3, 12731287.
  • Bilen J. and Bonini N. M. (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 3, 19501964.
  • Blard O., Feuillette S., Bou J., Chaumette B., Frebourg T., Campion D. and Lecourtois M. (2007) Cytoskeleton proteins are modulators of mutant tau-induced neurodegeneration in Drosophila. Hum. Mol. Genet. 16, 555566.
  • Blumenstiel J. P., Noll A. C., Griffiths J. A., Perera A. G., Walton K. N., Gilliland W. D., Hawley R. S. and Staehling-Hampton K. (2009) Identification of EMS-induced mutations in Drosophila melanogaster by whole-genome sequencing. Genetics 182, 2532.
  • Brand A. H. and Perrimon N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401415.
  • Butler E. K., Voigt A., Lutz A. K. et al. (2012) The mitochondrial chaperone protein TRAP1 mitigates alpha-Synuclein toxicity. PLoS Genet. 8, e1002488.
  • Cao W., Song H. J., Gangi T., Kelkar A., Antani I., Garza D. and Konsolaki M. (2008) Identification of novel genes that modify phenotypes induced by Alzheimer's beta-amyloid overexpression in Drosophila. Genetics 178, 14571471.
  • Chang H. C., Dimlich D. N., Yokokura T. et al. (2008) Modeling spinal muscular atrophy in Drosophila. PLoS ONE 3, e3209.
  • Chatterjee S., Sang T. K., Lawless G. M. and Jackson G. R. (2009) Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model. Hum. Mol. Genet. 18, 164177.
  • Choi C. M., Vilain S., Langen M., Van Kelst S., De Geest N., Yan J., Verstreken P. and Hassan B. A. (2009) Conditional mutagenesis in Drosophila. Science 324, 54.
  • Clark I. E., Dodson M. W., Jiang C., Cao J. H., Huh J. R., Seol J. H., Yoo S. J., Hay B. A. and Guo M. (2006) Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 11621166.
  • Cooley L., Kelley R. and Spradling A. (1988) Insertional mutagenesis of the Drosophila genome with single P elements. Science 239, 11211128.
  • Costa A. C., Loh S. H. and Martins L. M. (2013) Drosophila Trap1 protects against mitochondrial dysfunction in a PINK1/parkin model of Parkinson's disease. Cell Death Dis. 4, e467.
  • Dietzl G., Chen D., Schnorrer F. et al. (2007) A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature 448, 151156.
  • Doumanis J., Wada K., Kino Y., Moore A. W. and Nukina N. (2009) RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation. PLoS ONE 4, e7275.
  • Esposito G., Vos M., Vilain S., Swerts J., De Sousa Valadas J., Van Meensel S., Schaap O. and Verstreken P. (2013) Aconitase causes iron toxicity in Drosophila pink1 mutants. PLoS Genet. 9, e1003478.
  • Fernandes C. and Rao Y. (2011) Genome-wide screen for modifiers of Parkinson's disease genes in Drosophila. Mol. Brain 4, 17.
  • Fernandez-Funez P., Nino-Rosales M. L., de Gouyon B. et al. (2000) Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408, 101106.
  • Greene J. C., Whitworth A. J., Andrews L. A., Parker T. J. and Pallanck L. J. (2005) Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis. Hum. Mol. Genet. 14, 799811.
  • Greenspan R. J. (2004) Fly Pushing - The Theory and Practice of Drosophila Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
  • Higashiyama H., Hirose F., Yamaguchi M., Inoue Y. H., Fujikake N., Matsukage A. and Kakizuka A. (2002) Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ. 9, 264273.
  • Hoehne M., de Couet H. G., Stuermer C. A. and Fischbach K. F. (2005) Loss- and gain-of-function analysis of the lipid raft proteins Reggie/Flotillin in Drosophila: they are posttranslationally regulated, and misexpression interferes with wing and eye development. Mol. Cell. Neurosci. 30, 326338.
  • Hummel T. and Klambt C. (2008) P-element mutagenesis. Methods Mol. Biol. 420, 97117.
  • Ito K., Sass H., Urban J., Hofbauer A. and Schneuwly S. (1997) GAL4-responsive UAS-tau as a tool for studying the anatomy and development of the Drosophila central nervous system. Cell Tissue Res. 290, 110.
  • Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S. and Geschwind D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509519.
  • Kao C. F. and Lee T. (2013) Reverse genetics by loss-of-function mosaic analysis in Drosophila. Cold Spring Harb. Protoc. doi:10.1101/pdb.prot071670.
  • Kazemi-Esfarjani P. and Benzer S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 18371840.
  • Kennerdell J. R. and Carthew R. W. (2000) Heritable gene silencing in Drosophila using double-stranded RNA. Nat. Biotechnol. 18, 896898.
  • Kim H., Kim K., Kim J., Kim S. H. and Yim J. (2012) Mutagenesis by imprecise excision of the piggyBac transposon in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 417, 335339.
  • Kumar J. P. (2012) Building an ommatidium one cell at a time. Dev. Dyn. 241, 136149.
  • Latouche M., Lasbleiz C., Martin E. et al. (2007) A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes. J. Neurosci. 27, 24832492.
  • Lawal H. O., Terrell A., Lam H. A. et al. (2012) Drosophila modifier screens to identify novel neuropsychiatric drugs including aminergic agents for the possible treatment of Parkinson's disease and depression. Mol Psychiatry. doi: 10.1038/mp.2012.170.
  • Lessing D. and Bonini N. M. (2008) Polyglutamine genes interact to modulate the severity and progression of neurodegeneration in Drosophila. PLoS Biol. 6, e29.
  • Li L. B., Yu Z., Teng X. and Bonini N. M. (2008) RNA toxicity is a component of ataxin-3 degeneration in Drosophila. Nature 453, 11071111.
  • Llamusi B., Bargiela A., Fernandez-Costa J. M., Garcia-Lopez A., Klima R., Feiguin F. and Artero R. (2013) Muscleblind, BSF and TBPH are mislocalized in the muscle sarcomere of a Drosophila myotonic dystrophy model. Dis. Model Mech. 6, 184196.
  • Metaxakis A., Oehler S., Klinakis A. and Savakis C. (2005) Minos as a genetic and genomic tool in Drosophila melanogaster. Genetics, 171, 571581.
  • Nishimura I., Yang Y. and Lu B. (2004) PAR-1 kinase plays an initiator role in a temporally ordered phosphorylation process that confers tau toxicity in Drosophila. Cell 116, 671682.
  • Nusslein-Volhard C. and Wieschaus E. (1980) Mutations affecting segment number and polarity in Drosophila. Nature 287, 795801.
  • O'Kane C. J. and Gehring W. J. (1987) Detection in situ of genomic regulatory elements in Drosophila. Proc. Natl Acad. Sci. USA 84, 91239127.
  • Osterwalder T., Yoon K. S., White B. H. and Keshishian H. (2001) A conditional tissue-specific transgene expression system using inducible GAL4. Proc. Natl Acad. Sci. USA 98, 1259612601.
  • Park J., Lee S. B., Lee S. et al. (2006) Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441, 11571161.
  • Park J., Al-Ramahi I., Tan Q. et al. (2013) RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature 498, 325331.
  • Peter A., Schottler P., Werner M. et al. (2002) Mapping and identification of essential gene functions on the X chromosome of Drosophila. EMBO Rep. 3, 3438.
  • Rao D. D., Vorhies J. S., Senzer N. and Nemunaitis J. (2009) siRNA vs. shRNA: similarities and differences. Adv. Drug Deliv. Rev. 61, 746759.
  • Rong Y. S., Titen S. W., Xie H. B. et al. (2002) Targeted mutagenesis by homologous recombination in D. melanogaster. Genes Dev. 16, 15681581.
  • Rubin G. M., Yandell M. D., Wortman J. R. et al. (2000) Comparative genomics of the eukaryotes. Science 287, 22042215.
  • Ryder E. and Russell S. (2003) Transposable elements as tools for genomics and genetics in Drosophila. Brief. Funct. Genomic Proteomic 2, 5771.
  • Shulman J. M. and Feany M. B. (2003) Genetic modifiers of tauopathy in Drosophila. Genetics 165, 12331242.
  • Shulman J. M., Shulman L. M., Weiner W. J. and Feany M. B. (2003) From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease. Curr. Opin. Neurol. 16, 443449.
  • Spradling A. C., Stern D. M., Kiss I., Roote J., Laverty T. and Rubin G. M. (1995) Gene disruptions using P transposable elements: an integral component of the Drosophila genome project. Proc. Natl Acad. Sci. USA 92, 1082410830.
  • St Johnston D. (2002) The art and design of genetic screens: Drosophila melanogaster. Nat. Rev. Genet. 3, 176188.
  • Tan L., Schedl P., Song H. J., Garza D. and Konsolaki M. (2008) The Toll–>NFkappaB signaling pathway mediates the neuropathological effects of the human Alzheimer's Abeta42 polypeptide in Drosophila. PLoS ONE 3, e3966.
  • Thibault S. T., Singer M. A., Miyazaki W. Y. et al. (2004) A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat. Genet. 36, 283287.
  • Venken K. J. and Bellen H. J. (2012) Genome-wide manipulations of Drosophila melanogaster with transposons, Flp recombinase, and PhiC31 integrase. Methods Mol. Biol. 859, 203228.
  • Voßfeldt H., Butzlaff M., Prüßing K. et al. (2012) Large-scale screen for modifiers of ataxin-3-derived polyglutamine-induced toxicity in Drosophila. PLoS ONE 7, e47452.
  • Yang Y., Gehrke S., Haque M. E. et al. (2005) Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl Acad. Sci. USA 102, 1367013675.
  • Zhang S., Binari R., Zhou R. and Perrimon N. (2010) A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184, 11651179.
  • Zhang L., Karsten P., Hamm S. et al. (2013) TRAP1 rescues PINK1 loss-of-function phenotypes. Hum Mol Genet 22, 28292841.